News
  • About Us
  • Test serviecs
  • Regulations
  • R & D Service
  • News
  • Contact Us
  • Congratulations to Rainbowlabs for passing the CNAS inspecti

    2015-06-16 15:26:42
    Congratulations to Rainbowlabs for passing the CNAS inspecti
    A good news came that Rainbow Labs passed the site assessment of China National Accreditation Service for Conformity Assessment (CNAS) on November 9, 2014. At present, CNAS is the unique and most authoritative laboratory accreditation certification body. Being approved by CNAS, proves that our level and capacity are up to international standard, product inspection result reliable. The certificate or report issued by us, will be recognized by 56 countries in a mutual recognition system.

    Since then, Rainbow Labs becomes a laboratory which is approved and qualified by the US FDA, Health Canada and CNAS China at the same time. We will constantly make intensified effort on international registration and mutual recognition, unswervingly adhere to the strategy of quality innovation combined with the international high-end market access.
  • comments list

    [Diplomi_uspr  11月05日 20:40]  купить диплом о среднем специальном образовании отзывы https://r-diploma17.ru .
    [Diplomi_cakl  11月05日 20:37]  купить диплом о высшем образовании в саранске купить диплом о высшем образовании в саранске .
    [fixhef  11月05日 20:35]  If you are new to investing, these tips will help you save money. I especially liked the material about Practical tips for financial well-being with CactiCarely. The link is below: https://cacticarely.com/ Your financial well-being is in your hands!
    [TimothyRob  11月05日 20:33]  click to read https://drumrhythmstudio.com/
    [Michaelwal  11月05日 20:32]  more https://xyrantholpow.com
    Total 5720/66049 Pages Frist Prev Prev10  5711   5712   5713   5714   5715   5716   5717   5718   5719  5720 Next10 Next Last

    I want to comment

    content*
    Your name
    Verify code* 
  • Go Top
Shijiazhuang Rainbowlabs pharmaceutical Technology Co. Ltd  Copyright